Literature DB >> 8671219

Results of cytogenetic analysis in men with severe subfertility prior to intracytoplasmic sperm injection.

A A Baschat1, W Küpker, S al Hasani, K Diedrich, E Schwinger.   

Abstract

Intracytoplasmic sperm injection (ICSI) is increasingly becoming the treatment of choice for severe male subfertility. Cytogenetic evaluation of men with andrological subfertility reveals an increased incidence of chromosomal abnormalities when compared with the normal population. We performed chromosomal analysis on the male partners of 32 couples referred for andrological subfertility. In two of these men, constitutional chromosomal translocations were diagnosed prior to ICSI [(45,XY,t(21;22)(p11;q11) and 46,XY,t(22;Y)(p11;q12)]. Since ICSI bypasses many potential barriers of fertilization, successful pregnancy can be achieved despite the presence of severely impaired spermatozoa in a population at high risk for chromosomal aberrations. It is well known that the presence of a chromosomal aberration plays a significant role in partial or complete spermatogenic arrest. ICSI does not seem to increase the risk of fetal chromosomal abnormalities when a spermatozoon from a chromosomally normal male is used. To exclude a higher risk for spontaneous abortion and fetal chromosomal abnormalities, we advocate cytogenetic screening of males with severe male subfertility who opt for ICSI.

Entities:  

Mesh:

Year:  1996        PMID: 8671219     DOI: 10.1093/humrep/11.2.330

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Intracytoplasmic sperm injection. Karyotyping should be done before treatment.

Authors:  W Buckett; L Aird; M Luckas; C Kingsland; I Lewis-Jones; P Howard
Journal:  BMJ       Date:  1996-11-23

2.  A retrospective follow-up study on intracytoplasmic sperm injection.

Authors:  R Van Golde; M Boada; A Veiga; J Evers; J Geraedts; P Barri
Journal:  J Assist Reprod Genet       Date:  1999-05       Impact factor: 3.412

3.  DNA fragmentation, mitochondrial dysfunction and chromosomal aneuploidy in the spermatozoa of oligoasthenoteratozoospermic males.

Authors:  Chung-Hsien Liu; Hui-Mei Tsao; Tzu-Chun Cheng; Hui-Mei Wu; Chun-Chia Huang; Chung-I Chen; David Pei-cheng Lin; Maw-Sheng Lee
Journal:  J Assist Reprod Genet       Date:  2004-04       Impact factor: 3.412

4.  Chromosomal abnormalities in patients with oligozoospermia and non-obstructive azoospermia.

Authors:  Larysa Y Pylyp; Lyudmyla O Spinenko; Natalia V Verhoglyad; Valery D Zukin
Journal:  J Assist Reprod Genet       Date:  2013-04-11       Impact factor: 3.412

Review 5.  Cytogenetic determinants of male fertility.

Authors:  R H Martin
Journal:  Hum Reprod Update       Date:  2008-06-04       Impact factor: 15.610

6.  Chromosomal abnormalities in infertile men with azoospermia and severe oligozoospermia in Qatar and their association with sperm retrieval intracytoplasmic sperm injection outcomes.

Authors:  Mohamed M Arafa; Ahmad Majzoub; Sami S AlSaid; Walid El Ansari; Abdulla Al Ansari; Yara Elbardisi; Haitham T Elbardisi
Journal:  Arab J Urol       Date:  2017-12-23

Review 7.  A Schematic Overview of the Current Status of Male Infertility Practice.

Authors:  Ashok Agarwal; Ahmad Majzoub; Neel Parekh; Ralf Henkel
Journal:  World J Mens Health       Date:  2019-07-12       Impact factor: 5.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.